Ascites Clinical Trial
Official title:
Impact of Palliative Catheter Placement on the Quality of Life of Patients With Refractory Ascites
NCT number | NCT01188746 |
Other study ID # | 10-059 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | August 2010 |
Est. completion date | February 2020 |
Verified date | February 2020 |
Source | Memorial Sloan Kettering Cancer Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is look at how treatments for ascites affect quality of life. Your
quality of life is the ability for you to enjoy the normal things you do. Ascites (pronounced
as-ī-tees) is the presence of extra fluid in the abdomen. Sometimes ascites is caused by
cancer, also called malignancy.
All people who participate in this study have ascites associated with cancer. Ascites can
cause symptoms that make it difficult for the patient to do simple things. Patients with
ascites often report:
Abdominal swelling Difficulty walking. Difficulty breathing. Feeling full when eating.
Clothes not fitting due to a swollen abdomen. Swelling in the legs. It is hoped that this
catheter will relieve the symptoms of the ascites. The goal of the investigators study is to
understand the quality of life before the procedure and after the procedure. Since the
patient is having this procedure to make their symptoms better, the investigators want to
hear from the patient of how the procedure has affected their quality of life.
Status | Completed |
Enrollment | 50 |
Est. completion date | February 2020 |
Est. primary completion date | February 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patients diagnosed with a stage IV malignancy or end-stage disease documented in patient's chart. - Patients referred to interventional radiology for treatment of refractory ascites with the placement of a permanent catheter including, but not limited to, a Tenckhoff catheter, a PleurX catheter, or a Denver Shunt. - Fluency in English to enable instrument and interview completion. - Patients must be at least 18 years of age. - Patients must be physically capable of completing instruments and/or interview. - Patients must be able to comprehend and execute informed consent. Exclusion Criteria: - Unable to complete questionnaire due to a significant physical or mental deficits as assessed by the consenting professional. - Proxy completion is not accepted - Medical or psychiatric condition that, in the judgment of the investigator, prevents appropriate comprehension and execution of either the informed consent or the study instrument |
Country | Name | City | State |
---|---|---|---|
United States | Memorial Sloan Kettering Cancer Center | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Memorial Sloan Kettering Cancer Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Determine if there is change in the QoL | of patients who have refractory ascites after the placement of a palliative catheter in Interventional Radiology. | 2 years | |
Primary | Determine if there is change in symptoms | of patients who have refractory ascites after the placement of a palliative catheter in Interventional Radiology. | 2 years | |
Secondary | Determine the impact ascites has on quality of life | via patient interviews and how this is affected by catheter placement. | 2 years | |
Secondary | Monitor and describe post-catheter placement morbidity and mortality. | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02891642 -
Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
|
||
Recruiting |
NCT00239096 -
Prevention of Decompensation in Liver Cirrhosis
|
Phase 4 | |
Active, not recruiting |
NCT03973866 -
Alfapump® System in the Treatment of Refractory or Recurrent Ascites (POSEIDON Study)
|
N/A | |
Terminated |
NCT01455246 -
Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis
|
Phase 2/Phase 3 | |
Completed |
NCT01349348 -
Phase III Study of Tolvaptan Tablet to Treat Cirrhosis Ascites
|
Phase 3 | |
Completed |
NCT01578226 -
Procalcitonin in Cirrhotic Patients at High Risk for Sepsis
|
N/A | |
Terminated |
NCT00548366 -
Sodium Restriction in the Management of Cirrhotic Ascites
|
Phase 4 | |
Recruiting |
NCT05025878 -
13C-Glucose Tracing of Tumour and T Cells in the Ascites of Ovarian Cancer Patients.
|
||
Completed |
NCT03327688 -
Point-of-care Ultrasound in Finland
|
N/A | |
Not yet recruiting |
NCT04550091 -
Role Of Multi-detector Computed Tomography In Differentiation Between Different Types Of Ascites
|
||
Completed |
NCT01769040 -
Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With Cirrhosis
|
Phase 4 | |
Not yet recruiting |
NCT01716611 -
Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites
|
Phase 4 | |
Recruiting |
NCT05511766 -
Allopurinol Versus Atorvastatin to Prevent Complications of Liver Cirrhosis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05700708 -
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Refractory Ascites
|
||
Completed |
NCT05013502 -
Empagliflozin in Diuretic Refractory Ascites
|
Phase 1 | |
Not yet recruiting |
NCT06436807 -
PMCF Study of the CE-marked Drainova® ArgentiC Catheter
|
||
Completed |
NCT03263598 -
Validation of Diagnostic Usefulness of the Random Urine Na/K Ratio for Replacement of 24hr Urine Na Excretion in Cirrhotic Patients With Ascites
|
||
Completed |
NCT00907673 -
The Automated Fluid Shunt (AFS)in Chronic Congestive Heart Failure
|
N/A | |
Suspended |
NCT00511394 -
Acute Hemodynamics of Albumin Versus Normal Saline in Cirrhosis
|
N/A | |
Terminated |
NCT00796861 -
Trial of Sunitinib for Refractory Malignant Ascites
|
Phase 2 |